FeesSafety
Pluang+

Klaviyo upgraded to Buy with 72% upside on strong growth, margin gains, and reduced risk from Shopify deal

Analyst Insights
13 Nov 2026, 17:27 WIB
Seeking Alpha
View Source
Bullish
Klaviyo upgraded to Buy with 72% upside on strong growth, margin gains, and reduced risk from Shopify deal

Klaviyo has been upgraded to a Buy rating with a $34 price target, implying a 72% upside. This upgrade reflects the company's reduced risk profile due to a stronger partnership with Shopify, which lowers dependency risks. Additionally, Klaviyo showed better-than-expected revenue growth and expanded its non-GAAP gross margin to 75% in Q3, helped by efficient infrastructure cost management. The company trades at a discount compared to peers despite strong growth, supported by international and enterprise market traction and a shift toward AI-native consumer solutions.

Klaviyo's recent rating upgrade and growth outlook provide context for the Technology sector's performance on Pluang. As of Nov 13, 2026 20:42 WIB, 94 of 150 priced Technology-sector US stocks rose while 48 fell. Among notable movers, OKTA gained 2.51% with 100% buy order activity and a typical hold time of 45 days, contrasting with CSCO and AMD, which declined by 2.95% and 2.57% respectively, despite longer hold times and differing buy/sell splits.

More News

Solo integrates human verification into JellyJelly app as AI agents bypass CAPTCHA tests.

Solo integrates human verification into JellyJelly app as AI agents bypass CAPTCHA tests.

Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...

Others
Bullish
59 minutes ago
U.S. AI-enabled ophthalmic diagnostic devices market to hit $267M by 2033 with 20.5% CAGR.

U.S. AI-enabled ophthalmic diagnostic devices market to hit $267M by 2033 with 20.5% CAGR.

The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...

Market News
Bullish
59 minutes ago
Medical display monitors market to grow to $4B by 2033 driven by digital imaging and healthcare modernization

Medical display monitors market to grow to $4B by 2033 driven by digital imaging and healthcare modernization

The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...

Market News
Bullish
1 hour ago
Oppenheimer downgrades Enovix amid production expansion and strategic shift despite revenue growth.

Oppenheimer downgrades Enovix amid production expansion and strategic shift despite revenue growth.

Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...

Market News
Bearish
1 hour ago
Nokia executive Pallavi Mahajan buys 89 shares at €7.63 each on Nov 12, 2026

Nokia executive Pallavi Mahajan buys 89 shares at €7.63 each on Nov 12, 2026

On November 12, 2026, Nokia executive Pallavi Mahajan acquired 89 shares of Nokia Corporation at a price of €7.63 per share. This insider purchase is officially reported under EU Market Abuse Regulation Article 19. Such transactions by company execut...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App